These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 22801411)

  • 1. Neuropeptide Y and posttraumatic stress disorder.
    Sah R; Geracioti TD
    Mol Psychiatry; 2013 Jun; 18(6):646-55. PubMed ID: 22801411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y (NPY) and posttraumatic stress disorder (PTSD): A translational update.
    Schmeltzer SN; Herman JP; Sah R
    Exp Neurol; 2016 Oct; 284(Pt B):196-210. PubMed ID: 27377319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of neuropeptide Y decreases responsiveness to neuropeptide Y.
    Corder KM; Li Q; Cortes MA; Bartley AF; Davis TR; Dobrunz LE
    Neuropeptides; 2020 Feb; 79():101979. PubMed ID: 31708112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y Impairs Retrieval of Extinguished Fear and Modulates Excitability of Neurons in the Infralimbic Prefrontal Cortex.
    Vollmer LL; Schmeltzer S; Schurdak J; Ahlbrand R; Rush J; Dolgas CM; Baccei ML; Sah R
    J Neurosci; 2016 Jan; 36(4):1306-15. PubMed ID: 26818517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide Y, resilience, and PTSD therapeutics.
    Kautz M; Charney DS; Murrough JW
    Neurosci Lett; 2017 May; 649():164-169. PubMed ID: 27913193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide S in the basolateral amygdala mediates an adaptive behavioral stress response in a rat model of posttraumatic stress disorder by increasing the expression of BDNF and the neuropeptide YY1 receptor.
    Cohen H; Vainer E; Zeev K; Zohar J; Mathé AA
    Eur Neuropsychopharmacol; 2018 Jan; 28(1):159-170. PubMed ID: 29157796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neuropeptide Y (NPY)-ergic system is associated with behavioral resilience to stress exposure in an animal model of post-traumatic stress disorder.
    Cohen H; Liu T; Kozlovsky N; Kaplan Z; Zohar J; Mathé AA
    Neuropsychopharmacology; 2012 Jan; 37(2):350-63. PubMed ID: 21976046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma neuropeptide Y concentrations in combat exposed veterans: relationship to trauma exposure, recovery from PTSD, and coping.
    Yehuda R; Brand S; Yang RK
    Biol Psychiatry; 2006 Apr; 59(7):660-3. PubMed ID: 16325152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex Differences in the Neuropeptide Y System and Implications for Stress Related Disorders.
    Nahvi RJ; Sabban EL
    Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32867327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptide Y and cannabinoids interaction in the amygdala after exposure to shock and reminders model of PTSD.
    Maymon N; Mizrachi Zer-Aviv T; Sabban EL; Akirav I
    Neuropharmacology; 2020 Jan; 162():107804. PubMed ID: 31622603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid neuropeptide Y in combat veterans with and without posttraumatic stress disorder.
    Sah R; Ekhator NN; Jefferson-Wilson L; Horn PS; Geracioti TD
    Psychoneuroendocrinology; 2014 Feb; 40():277-83. PubMed ID: 24485499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-exposure and environmental enrichment reveal NPY-Y1 as a possible target for post-traumatic stress disorder.
    Hendriksen H; Bink DI; Daniels EG; Pandit R; Piriou C; Slieker R; Westphal KG; Olivier B; Oosting RS
    Neuropharmacology; 2012 Sep; 63(4):733-42. PubMed ID: 22659471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of Neuropeptide Y in fear conditioning and extinction.
    Tasan RO; Verma D; Wood J; Lach G; Hörmer B; de Lima TC; Herzog H; Sperk G
    Neuropeptides; 2016 Feb; 55():111-26. PubMed ID: 26444585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DPP4-deficient congenic rats display blunted stress, improved fear extinction and increased central NPY.
    Canneva F; Golub Y; Distler J; Dobner J; Meyer S; von Hörsten S
    Psychoneuroendocrinology; 2015 Mar; 53():195-206. PubMed ID: 25635612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide Y: A stressful review.
    Reichmann F; Holzer P
    Neuropeptides; 2016 Feb; 55():99-109. PubMed ID: 26441327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locus coeruleus response to single-prolonged stress and early intervention with intranasal neuropeptide Y.
    Sabban EL; Laukova M; Alaluf LG; Olsson E; Serova LI
    J Neurochem; 2015 Dec; 135(5):975-86. PubMed ID: 26333000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of NPY Y1 receptor on acquisition, consolidation and extinction on contextual fear conditioning: dissociation between anxiety, locomotion and non-emotional memory behavior.
    Lach G; de Lima TC
    Neurobiol Learn Mem; 2013 Jul; 103():26-33. PubMed ID: 23603424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of neuropeptide Y for preventing or treating post-traumatic stress disorder.
    Sabban EL; Alaluf LG; Serova LI
    Neuropeptides; 2016 Apr; 56():19-24. PubMed ID: 26617395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NPY controls fear conditioning and fear extinction by combined action on Y₁ and Y₂ receptors.
    Verma D; Tasan RO; Herzog H; Sperk G
    Br J Pharmacol; 2012 Jun; 166(4):1461-73. PubMed ID: 22289084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential of Intranasal Neuropeptide Y (NPY) and/or Melanocortin 4 Receptor (MC4R) Antagonists for Preventing or Treating PTSD.
    Sabban EL; Serova LI
    Mil Med; 2018 Mar; 183(suppl_1):408-412. PubMed ID: 29635611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.